July 30 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its non-consolidated net profit edged up to 25.0 million levs ($14.3 million/12.8 million euro) in the first half of 2019, from 24.9 million levs in the same period of 2018.